Klr Investment Advisors, LLC Novartis Ag Transaction History

Klr Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$92.27 - $101.54 $971,234 - $1.07 Million	10,526 Added 150.14%	17,537 $1.77 Billion
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $351,164 - $389,716	-3,707 Reduced 34.59%	7,011 $645 Million
Q2 2023 Aug 08, 2023	BUY	$92.52 - $104.91 $316,325 - $358,687	3,419 Added 46.84%	10,718 $1.08 Billion
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $734,355 - $851,624	-9,176 Reduced 55.7%	7,299 $672 Million
Q4 2022 May 15, 2023	BUY	$75.55 - $92.52 $1.24 Million - $1.52 Million	16,475 New	16,475 $1.49 Billion

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Klr Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Klr Investment Advisors, LLC with notifications on news.